![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
In a move to expand its portfolio beyond antibiotics, Paratek Pharmaceuticals ha...
Human medicines European public assessment report (EPAR): Scintimun, besilesomab...
Human medicines European public assessment report (EPAR): Sivextro, tedizolid ph...
Two "concerned shareholders" are calling for an immediate strategic review at Am...
Global pharma giants AstraZeneca, Bristol Myers Squibb, Johnson & Johnson, Novar...
Zynex Medical disclosed that an insurer, a major client, was suspending payments...
Elevation is ditching its sole clinical-stage asset in the wake of disappointing...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
Monte Rosa Therapeutics’ plan to develop a molecular glue degrader in a wide ran...
Novo Nordisk may be reorganizing its early-stage R&D capabilities, but the Danis...
The most effective strategy against bird flu on chicken farms is prevention, wri...
In this edition of STAT's Health Tech newsletter: Does evidence support wider ad...
For the 80 million people worldwide who have celiac disease, the only treatment ...
And other biotech news brought to you by The Readout.
BioNTech has passed on Autolus Therapeutics’ dual targeting CAR-T cell therapy. ...
Aspen Pharmacare, the largest drugmaker on the African continent, was slammed in...
The FDA wants to end bulk production of copycat versions of weight loss drugs; t...
Read the Morning Rounds newsletter with all the health news stories you need to ...
Industry lobby group calls for action from government ahead of summit in April
Minutes of the HMPC meeting 20-22 January 2025
Opinions and letters of support on the qualification of novel methodologies for ...
EMA’s human medicines committee (CHMP) has issued the first Qualification Opinio...
The CD20-directed antibody, dubbed DR-0201, is a bispecific myeloid cell engager...
The CD20-directed antibody, dubbed DR-0201, is a bispecific myeloid cell engager...